GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (FRA:49Z) » Definitions » Ending Cash Position

BICO Group AB (FRA:49Z) Ending Cash Position : €64.7 Mil (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is BICO Group AB Ending Cash Position?

BICO Group AB's Ending Cash Position for the quarter that ended in Mar. 2025 was €64.7 Mil.

BICO Group AB's quarterly Ending Cash Position increased from Sep. 2024 (€60.1 Mil) to Dec. 2024 (€82.3 Mil) but then declined from Dec. 2024 (€82.3 Mil) to Mar. 2025 (€64.7 Mil).

BICO Group AB's annual Ending Cash Position declined from Dec. 2022 (€84.2 Mil) to Dec. 2023 (€77.0 Mil) but then increased from Dec. 2023 (€77.0 Mil) to Dec. 2024 (€82.3 Mil).

BICO Group AB Ending Cash Position Historical Data

The historical data trend for BICO Group AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB Ending Cash Position Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 78.45 46.85 84.16 76.97 82.27

BICO Group AB Quarterly Data
Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.31 60.91 60.10 82.27 64.73

BICO Group AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BICO Group AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=74.86+7.408
=82.3

BICO Group AB's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=86.394+-21.662
=64.7

BICO Group AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BICO Group AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BICO Group AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (FRA:49Z) » Definitions » Ending Cash Position
Comparable Companies
OSTO:CEVI OSTO:PAX OSTO:OSSD OSTO:BACTI B OSTO:SEDANA OSTO:CRAD B OSTO:SEZI OSTO:MNTC OSTO:PRO OSTO:BRAIN ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
CLLKF:USA BICO:Sweden
Address
Langfilsgatan 9, Gothenburg, SWE, 41277
Website
https://www.bico.com
BICO Group AB is a bio-convergence company. The company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Group consists of three reporting segments: Bioprinting, Life Science Solutions, and Lab Automation. Bioprinting consists of CELLINK, MatTek, Visikol, and Advanced BioMatrix. Life Science Solutions consists of CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, and Cellenion. Lab Automation consists of Biosero.

BICO Group AB Headlines

No Headlines